ポスト
ANKTIVA: A Breakthrough in the Treatment of Non-Muscle Invasive Bladder Cancer $IBRX In a recent series of podcasts conducted by UroToday, ImmunityBio, Inc. reveals groundbreaking developments in the field of bladder cancer research and the FDA approv…
メニューを開く